ABM Q3 FY26 GAAP net income rises 19% to $49.7 million; revenue climbs 4.2% to $2.3 billion
Reuters2026/09/08 11:19Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- ABM Industries posted fiscal Q3 revenue of $2.3 billion, up 4.2% year over year, including 2.1% organic growth.
- GAAP net income climbed 19% to $49.7 million; GAAP EPS rose 25% to $0.84.
- Adjusted EBITDA increased 11% to $139.6 million; segment operating margin was 7.7%, flat year over year.
- Aviation revenue rose 12.5% to $328.1 million on healthy domestic travel and the Heathrow contract ramp.
- Full-year adjusted EPS outlook was raised to $3.95-$4.10; free cash flow reached $199.6 million year to date.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABM Industries Incorporated published the original content used to generate this news brief on September 04, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Longest in Five Years! US Stock Earnings Upward Revision Trend Hits Record Since 2021, May Signal Another Profitable Earnings Season Ahead
Supported by strong corporate earnings prospects, U.S. stocks are demonstrating considerable resilience and are withstanding the impact of rising inflationary pressures.
智通财经•2026/09/08 11:46

Australian Dollar: RBA inflation focus underpins carry – BBH
FXStreet•2026/09/08 11:39
Pharvaris Says Phase 3 Deucrictibant XR Trial Meets Endpoints in Hereditary Angioedema
MT newswire•2026/09/08 11:39
Crypto prices
MoreBitcoin
BTC
$78,370.13
-1.32%
Ethereum
ETH
$2,473.17
-0.70%
Tether USDt
USDT
$0.9996
-0.03%
BNB
BNB
$751.52
+1.03%
XRP
XRP
$1.39
-0.33%
USDC
USDC
$1.0000
+0.00%
Solana
SOL
$102.9
-1.90%
TRON
TRX
$0.3385
+0.63%
Hyperliquid
HYPE
$83.39
-4.98%
Zcash
ZEC
$1,163.46
-2.72%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now